Literature DB >> 24163084

Expression and clinical significance of STIP1 in papillary thyroid carcinoma.

Meng-Hui Yuan1, Run-Suo Zhou, Bei She, Hai-Feng Xu, Jun-Yan Wang, Long-Xiao Wei.   

Abstract

The aim of this study was to detect stress-induced phosphoprotein 1 (STIP1) expression in papillary thyroid carcinoma (PTC) and to analyze its association with prognosis of PTC patients. Immunohistochemistry was performed to detect the expression of STIP1 in 113 PTC tissues and paired adjacent noncancerous tissues. The χ2 test was used to analyze the relationship between STIP1 expression and clinicopathological characteristics. Survival curves were plotted by the Kaplan-Meier method and compared using the log-rank test. Survival data was evaluated using univariate and multivariate Cox regression analysis. We identified abnormally elevated expression of STIP1 protein in PTC tissues compared to paired adjacent noncancerous tissues. Clinicopathological analysis showed that STIP1 expression was significantly correlated with tumor size (P = 0.017), lymph node metastasis (P = 0.007), and TNM stage (P = 0.026). Patients with higher STIP1 expression had shorter overall survival time, whereas those with lower STIP1 expression had longer survival time. Multivariate analysis suggested that STIP1 expression might be an independent prognostic indicator (P < 0.05) for the survival of patients with PTC. In conclusion, our findings provide evidences that positive expression of STIP1 in PTC may be important in the acquisition of an aggressive phenotype, and it is an independent biomarker for poor prognosis of patients with PTC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24163084     DOI: 10.1007/s13277-013-1316-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

1.  The architecture of functional modules in the Hsp90 co-chaperone Sti1/Hop.

Authors:  Andreas B Schmid; Stephan Lagleder; Melissa Ann Gräwert; Alina Röhl; Franz Hagn; Sebastian K Wandinger; Marc B Cox; Oliver Demmer; Klaus Richter; Michael Groll; Horst Kessler; Johannes Buchner
Journal:  EMBO J       Date:  2012-01-06       Impact factor: 11.598

2.  Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.

Authors:  Tzu-Hao Wang; Angel Chao; Chia-Lung Tsai; Chih-Long Chang; Shun-Hua Chen; Yun-Shien Lee; Jen-Kun Chen; Yi-Jun Lin; Pi-Yueh Chang; Chin-Jung Wang; An-Shine Chao; Shuenn-Dyh Chang; Ting-Chang Chang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

3.  Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone.

Authors:  Jong-Lyel Roh; Jae-Yong Park; Chan Il Park
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

Review 4.  Investigating the thyroid nodule.

Authors:  H M Mehanna; A Jain; R P Morton; J Watkinson; A Shaha
Journal:  BMJ       Date:  2009-03-13

5.  The Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

6.  Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.

Authors:  Sunghoon Kim; Hanbyoul Cho; Eun Ji Nam; Sang Wun Kim; Young Tae Kim; Yong Won Park; Bo Wook Kim; Jae-Hoon Kim
Journal:  Genes Chromosomes Cancer       Date:  2010-07       Impact factor: 5.006

Review 7.  Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging.

Authors:  G H Tan; H Gharib
Journal:  Ann Intern Med       Date:  1997-02-01       Impact factor: 25.391

8.  STI1 promotes glioma proliferation through MAPK and PI3K pathways.

Authors:  Rafael B Erlich; Suzana A Kahn; Flávia R S Lima; Angelita G Muras; Rodrigo A P Martins; Rafael Linden; Luciana B Chiarini; Vilma R Martins; Vivaldo Moura Neto
Journal:  Glia       Date:  2007-12       Impact factor: 7.452

9.  Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.

Authors:  Wei Sun; Baocai Xing; Yi Sun; Xiaojuan Du; Min Lu; Chunyi Hao; Zhuang Lu; Wei Mi; Songfeng Wu; Handong Wei; Xue Gao; Yunping Zhu; Ying Jiang; Xiaohong Qian; Fuchu He
Journal:  Mol Cell Proteomics       Date:  2007-07-12       Impact factor: 5.911

10.  Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer.

Authors:  Angel Chao; Chyong-Huey Lai; Chia-Lung Tsai; Swei Hsueh; Chuen Hsueh; Chiao-Yun Lin; Hung-Hsueh Chou; Yu-Jr Lin; Hsi-Wen Chen; Ting-Chang Chang; Tzu-Hao Wang
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more
  4 in total

1.  HOP expression is regulated by p53 and RAS and characteristic of a cancer gene signature.

Authors:  Stacey A Mattison; Gregory L Blatch; Adrienne L Edkins
Journal:  Cell Stress Chaperones       Date:  2016-12-16       Impact factor: 3.667

2.  Tumor stress-induced phosphoprotein 1 as a prognostic biomarker for breast cancer.

Authors:  Ruxing Wu; Fei Liu; Ping Peng; Hong Qiu; Huihua Xiong; Shiying Yu; Xiaoyuan Huang; Hanwang Zhang; Liang Zhuang
Journal:  Ann Transl Med       Date:  2018-08

3.  STIP1/HOP Regulates the Actin Cytoskeleton through Interactions with Actin and Changes in Actin-Binding Proteins Cofilin and Profilin.

Authors:  Samantha Joy Beckley; Morgan Campbell Hunter; Sarah Naulikha Kituyi; Ianthe Wingate; Abantika Chakraborty; Kelly Schwarz; Matodzi Portia Makhubu; Robert Pierre Rousseau; Duncan Kyle Ruck; Jo-Anne de la Mare; Gregory Lloyd Blatch; Adrienne Lesley Edkins
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

4.  The Expression of FOXE-1 and STIP-1 in Papillary Thyroid Carcinoma and Their Relationship with Patient Prognosis.

Authors:  Enas M Fouad; Ola A Harb; Salem Reham Amin; Ola M El Farargy; Fady M Habib; Loay M Gertallah
Journal:  Iran J Pathol       Date:  2018-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.